生物防御市场规模、份额、成长分析（按产品、应用、最终用户、地区）- 2025 年至 2032 年产业预测

2023 年全球生物防御市场规模为 144 亿美元，预计将从 2024 年的 152.9 亿美元成长到 2032 年的 247.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.2%。

生物防御市场的成长受到政府强有力的倡议、私人投资的活性化以及针对流感、兹卡和伊波拉出血热等流行病的生物防御战略支出增加的推动。基因工程和生物技术的最新进展使得修改致命病毒成为可能，这引发了人们对潜在生物武器威胁的担忧。针对过去曾被用于生物恐怖主义的各种生物製药，如炭疽菌和肉毒桿菌，世界各国政府都采取了严格的措施、条约和政策来对抗生物威胁并最大限度地降低风险。自2001年炭疽菌袭击事件以来，国家感染疾病研究所在感染疾病研究中发挥了关键作用，并为开发医疗产品和打击生物恐怖主义的策略做出了贡献，凸显了市场对全球卫生安全的重要性。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

生物防御市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 疫苗
  • 炭疽菌
  • 天花
  • 肉毒桿菌中毒
  • 其他的
• 生物威胁侦测装置
  • 采样器
  • 检测器/触发装置
  • 识别符
  • 检测方法和试剂

生物防御市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 军队
• 平民

生物防御市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 门诊治疗中心
• 其他的

生物防御市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Emergent BioSolutions Inc.（United States）
• SIGA Technologies, Inc.（United States）
• Dynavax Technologies Corporation（United States）
• Altimmune Inc.（United States）
• XOMA Corporation（United States）
• Cleveland BioLabs Inc.（United States）
• Ichor Medical Systems, Inc.（United States）
• ANP Technologies, Inc.（United States）
• PositiveID Corporation（United States）
• Alexeter Technologies LLC（United States）
• BioFire Defense（bioMerieux SA）（United States）
• Elusys Therapeutics Inc.（United States）
• Battelle National Biodefense Institute, LLC（United States）
• Gryphon Scientific LLC（United States）
• BioRisk Reduction（United States）
• CBRNe Science and Consequence Management World Congress（United States）
• Mammoth Biosciences（United States）
• Alnylam Pharmaceuticals Inc.（United States）
• Bruker Detection（United States）
• New Horizon Diagnostic Corp.（United States）

结论和建议

Global Biodefense Market size was valued at USD 14.4 billion in 2023 and is poised to grow from USD 15.29 billion in 2024 to USD 24.74 billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).

The growth of the biodefense market is fueled by robust government initiatives, heightened private investments, and increased spending focused on biodefense strategies in response to outbreaks like flu, Zika, and Ebola. Recent technological advancements in genetic engineering and biotechnology enable the modification of deadly viruses, raising concerns about potential bioweapon threats. With various biological agents previously used in bioterrorism-such as anthrax and botulism-governments worldwide are adopting stringent biodefense measures, treaties, and policies to combat biological threats and minimize risks. The National Institute of Infectious Disease plays a crucial role in researching infectious diseases, contributing to the development of medical products and strategies to tackle bioterrorism since the 2001 anthrax attacks, underscoring the market's significance in global health security.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segments Analysis

Global Biodefense Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Vaccines and Biothreat Detection Devices. Based on Application, the market is segmented into Military and Civilian. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biodefense Market

The Global Biodefense market is significantly driven by substantial investments from federal and state governments aimed at enhancing national and public health security. These expenditures are essential for the development of vaccines, diagnostics, and treatments that ensure healthcare systems are well-prepared for potential biological threats. Furthermore, governments are channeling funds into emergency planning, infrastructure, and training, creating an environment conducive to the advancement of innovative biodefense strategies. This proactive approach not only bolsters preparedness against biological attacks but also strengthens resilience in the face of pandemics, thereby significantly influencing market growth and development.

Restraints in the Global Biodefense Market

The global biodefense market faces significant challenges due to intense competition among established companies, which can result in price wars and diminished profit margins. This competitive landscape poses barriers for new entrants seeking to penetrate the market. Larger enterprises typically wield considerable resources and maintain established connections with regulatory authorities, allowing them to exert substantial influence. To safeguard their market share, these dominant firms may adopt aggressive pricing strategies that not only compress profits but also stifle the growth potential of smaller companies. Consequently, this dynamic creates a challenging environment for emerging players in the vital biodefense sector.

Market Trends of the Global Biodefense Market

The Global Biodefense market is increasingly influenced by the rising trend of personalized medicine, which focuses on developing customized vaccines and treatments tailored to specific demographics and biological threats. This innovative approach enhances response mechanisms to infectious diseases, allowing for more effective public health strategies. As advancements in genomics and biotechnology progress, researchers anticipate the creation of highly effective vaccines designed to align with the unique genetic profiles of diverse populations. Consequently, this trend not only promises to improve individual health outcomes but also strengthens national biodefense strategies by enabling targeted and efficient responses to emerging infectious threats.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biodefense Market Size by Product & CAGR (2025-2032)

• Market Overview
• Vaccines
  • Anthrax
  • Smallpox
  • Botulism
  • Others
• Biothreat Detection Devices
  • Samplers
  • Detectors/Triggering Devices
  • Identifiers
  • Assays and Reagents

Global Biodefense Market Size by Application & CAGR (2025-2032)

• Market Overview
• Military
• Civilian

Global Biodefense Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Global Biodefense Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Emergent BioSolutions Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGA Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XOMA Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland BioLabs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ichor Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANP Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PositiveID Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexeter Technologies LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioFire Defense (bioMerieux SA) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elusys Therapeutics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Battelle National Biodefense Institute, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gryphon Scientific LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRisk Reduction (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CBRNe Science and Consequence Management World Congress (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alnylam Pharmaceuticals Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Detection (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New Horizon Diagnostic Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations